OAKLAND, N.J. — Topcon Healthcare shared its latest research findings at the Association for Research in Vision and Ophthalmology (ARVO) 2026 conference. The clinical work underscored the role of ocular imaging, artificial intelligence, oculomics and connected care technologies in advancing ophthalmic research and broader healthcare innovation.
Topcon presented 80 abstracts and 11 presentations across ARVO and the Imaging in the Eye scientific event. Related research was also presented among three ARVO Hot Topics recognitions, selected for their relevance to emerging areas shaping the future of medicine and vision research leveraging artificial intelligence (AI)-based approaches.
“This continued growth reflects the increasing importance of advanced retinal imaging, AI and connected care in driving scientific discovery,” said Daniela Ferrara, MD, PhD, Chief Medical Officer, Topcon Healthcare. “We are proud to empower researchers and clinicians with innovative technologies that enable deeper clinical insights, more data-driven decision-making and new opportunities for earlier detection of vision-threatening and systemic diseases. The inspiring momentum at ARVO also reinforces the growing recognition that the eye can serve as a powerful, non-invasive window into overall health and healthy aging through the science of oculomics.”
Topcon’s Activities at ARVO
As part of its ARVO 2026 activities, Topcon Healthcare hosted an educational symposium, “AI as the Bridge to Connected Care.” The session explored the role of AI and advanced retinal imaging in identifying biomarkers for retinal, cardiovascular, metabolic and neurodegenerative diseases. The program also highlighted the potential of AI-enabled endpoints, real-world data and connected care models to transform clinical research and patient care.
Topcon Healthcare also co-sponsored the spring meeting of the Alliance for Healthcare from the Eye (AHE). This was a collaborative forum focused on advancing the responsible use of data, AI and connected care models to improve disease detection, patient access and health outcomes. The meeting brought together stakeholders committed to Healthcare from the Eye by exploring how insights from ocular data can contribute to the future of preventive, personalized, data-driven management of serious systemic and ocular diseases.
Together, Topcon Healthcare’s scientific presence at ARVO 2026, the “AI as the Bridge to Connected Care” symposium and the Alliance for Healthcare from the Eye meeting reflect a broader shift in medicine, which is the growing recognition that the eye can provide critical insights into both ocular and systemic health.
Read the latest AI in Eye Care news here
Author
